BioProcess International (BPI)
Bioprocessing Insights
Expert insights, start-up stories and resources for bioprocessing, biomanufacturing, cell culture development, upstream and downstream processing knowledge.
Talk of the Town: Sessions to Watch for at BioProcess International and Cell & Gene Therapy 2026
BPI & CGT 2026 offer a breadth of exciting sessions in different tracks – from cell line development and engineering, upstream and cell culture, downstream processing, digital biomanufacturing and CMC strategy to development of emerging cell and gene therapies, cell therapy manufacturing and analytics, and gene therapy.
Beyond your topic of interest, how do you choose which sessions to attend this year? Find out what sessions our speakers are going to be watching.
Start-Up Stories
Discover the innovative biotech startups reshaping healthcare's future—their bold visions, breakthrough technologies, and the passionate founders behind them.
Aurion Biotech is a pioneering clinical-stage company developing cell therapies for vision restoration. Its technology creates up to 1,000 treatments from a single donor cornea, addressing the critical global shortage of transplantable tissue.
Discover the innovative journey of Nanite Inc, a company combining AI-driven polymer design with multiplexed in vivo screening to develop best-in-class nanoparticles engineered for tissue-specific delivery.
Eric Halioua, CEO of PDCline Pharma, discusses his journey in founding and developing a biotechnology company focused on innovative cancer vaccines. Eric shares his background in the biotech industry, the founding story of PDCline Pharma, and the company's development of a novel therapeutic platform using a unique dendritic cell line to stimulate immune responses against cancer.
David Howell, co-founder of Bondwell Technologies, a start-up developing protein-based biomaterials. Founded in 2017, by Texas A&M University scientists and headquartered in College Station, Texas, the company is commercializing a unique platform technology with applications across energy, environment, and medicine.
Key topics being explored at BioProcess International
How are sustainability initiatives reshaping bioprocess facility design and operations?
Sustainability has become a strategic imperative in bioprocessing, with companies implementing water recycling systems, energy-efficient equipment, and waste reduction protocols that significantly lower environmental footprints. Leading organizations are reporting up to 40% reductions in water consumption and 30% decreases in carbon emissions through innovative facility designs and process optimizations that simultaneously enhance operational efficiency and environmental performance.
How are digital maturity models transforming bioprocess development and manufacturing operations?
Digital maturity frameworks are guiding strategic technology implementation across the bioprocessing value chain, enabling organizations to systematically advance their capabilities from basic digitalization to fully integrated smart manufacturing. Companies implementing these structured approaches are reporting 25-40% improvements in development efficiency and manufacturing performance through targeted digital investments aligned with business objectives.
What strategies are emerging to address raw material variability and supply chain resilience?
Advanced supplier integration models, real-time raw material characterization technologies, and AI-powered supply chain analytics are transforming how companies manage material variability and supply risks. These approaches enable proactive identification of potential disruptions and rapid adaptation of manufacturing processes to accommodate material differences without compromising product quality.
What innovations are improving upstream bioprocessing efficiency?
Recent innovations in upstream bioprocessing focus on automated cell culture systems, advanced media formulations, and real-time monitoring technologies that significantly increase productivity while maintaining product quality. These advancements are helping companies achieve higher titers and more consistent manufacturing outcomes with fewer resources.
What downstream processing advances are solving purification bottlenecks?
New chromatography technologies, membrane-based separations, and continuous purification systems are addressing the bottlenecks traditionally associated with downstream processing. These innovations enable more efficient handling of high-titer feed streams while improving product quality and reducing processing times.
Join the community!
Ready to connect with industry leaders and unlock exclusive insights?
Join our LinkedIn community and stay ahead of the curve!